Skip to main content
. 2022 Feb 16;12:2582. doi: 10.1038/s41598-022-05838-z

Table 2.

Significant (P < 5e−08) SNPs and genetic loci associated with bacterial and viral infections in the GWAS.

Phenotype SNP CH Position (b37) Effect allele Other allele EAF cases EAF controls Odds ratio (95% CI) Beta SE P MACH-Rsq Nearby genes (+ / − 100 kb)
Abdominal infections rs6717024 2 144,308,780 C G 0.2 0.18 1.133 (1.111–1.156) 0.125 0.010 1.22e−34 1.00 ARHGAP15
rs4333882 1 234,352,899 G A 0.2 0.19 1.081 (1.060–1.103) 0.078 0.010 2.14e−14 0.97 MIR4671, SLC35F3
rs7609897 3 15,502,681 T G 0.2 0.21 0.925 (0.907–0.943) − 0.078 0.010 9.76e−14 0.91 COLQ, EAF1, HACL1, METTL6, MIR4270
rs760364725 19 38,757,315 CA C 0.49 0.48 1.062 (1.045–1.079) 0.060 0.008 5.59e−13 0.94 C19orf33, CATSPERG, DPF1, KCNK6, PPP1R14A, SIPA1L3, SPINT2, YIF1B
rs61823192 1 219,294,570 T C 0.026 0.03 0.828 (0.785–0.873) − 0.189 0.027 1.26e−12 0.90 LYPLAL1, LYPLAL1-DT
rs1802575 2 56,093,204 C G 0.14 0.13 1.081 (1.056–1.107) 0.078 0.012 1.56e−11 1.00 EFEMP1, MIR217HG
rs11428277 10 101,425,013 G GA 0.19 0.18 1.075 (1.052–1.098) 0.072 0.011 1.69e−11 0.91 COX15, CUTC, ENTPD7, SLC25A28
rs570640158 6 32,517,793 C T 0.27 0.26 1.070 (1.050–1.092) 0.068 0.010 2.13e−11 0.81 HLA-DQA1, HLA-DRB1, HLA-DRB5, HLA-DRB6
rs4782673 16 84,884,072 T G 0.28 0.3 0.945 (0.928–0.961) − 0.057 0.009 1.37e−10 1.00 CRISPLD2, USP10
rs7464710 8 120,624,386 G C 0.25 0.26 0.943 (0.926–0.959) − 0.059 0.009 4.13e−10 0.98 ENPP2
rs2049865 8 116,588,546 C A 0.41 0.42 0.950 (0.935–0.965) − 0.051 0.008 4.67e−10 0.98 TRPS1
rs61817723 1 151,920,865 A G 0.27 0.28 0.945 (0.928–0.961) − 0.057 0.009 4.71e−10 0.99 C2CD4D-AS1, NBPF18P, S100A10, S100A11, THEM4, THEM5
rs2276068 11 70,007,484 C G 0.49 0.48 1.050 (1.034–1.067) 0.049 0.008 1.04e−09 1.00 ANO1, FADD, LINC02584, LOC101928443
rs9372625 6 98,344,031 A G 0.37 0.38 0.951 (0.936–0.966) − 0.050 0.008 2.02e−09 0.99
rs2280028 16 86,233,413 A G 0.13 0.14 0.932 (0.911–0.955) − 0.070 0.012 3.23e−09 0.99 LINC01081, LINC01082, LINC02135
rs71472433 15 40,649,609 C A 0.17 0.17 1.064 (1.041–1.087) 0.062 0.011 5.24e−09 0.99 ANKRD63, BAHD1, BUB1B-PAK6, CCDC9B, DISP2, INAFM2, IVD, KNSTRN, PAK6, PHGR1, PLCB2
rs2973068 5 37,778,273 G C 0.24 0.25 0.947 (0.931–0.964) − 0.054 0.009 8.15e−09 0.99 GDNF, GDNF-AS1, WDR70
rs761264338 7 102,444,156 GGAAG G 0.34 0.33 1.050 (1.032–1.069) 0.049 0.009 1.03e−08 0.98 FAM185A, FBXL13, RASA4DP
rs1888693 10 18,440,444 A G 0.33 0.34 0.952 (0.936–0.969) − 0.049 0.009 1.14e−08 1.00 CACNB2
rs3732760 3 151,074,941 C A 0.38 0.37 1.048 (1.032–1.065) 0.047 0.008 1.17e−08 1.00 GPR87, IGSF10, MED12L, P2RY12, P2RY13, P2RY14
rs575909118 11 15,065,235 CT C 0.27 0.27 1.053 (1.035–1.072) 0.052 0.009 1.40e−08 0.98 CALCA, CALCB, INSC
rs11030119 11 27,728,102 A G 0.3 0.31 0.951 (0.935–0.968) − 0.050 0.009 1.44e−08 1.00 BDNF, BDNF-AS, LINC00678
rs60731259 7 73,439,465 CA C 0.066 0.061 1.096 (1.063–1.131) 0.092 0.016 1.96e−08 0.99 ELN, LIMK1
rs9411377 9 136,145,404 A C 0.28 0.29 0.950 (0.934–0.967) − 0.051 0.009 2.01e−08 0.96 MED22, OBP2B, RPL7A, SNORD24, SNORD36A, SNORD36B, SNORD36C, STKLD1, SURF1, SURF2, SURF4, SURF6
rs377411728 18 6,305,754 T C 0.00071 0.00031 2.641 (1.878–3.714) 0.971 0.174 2.42e−08 0.83 L3MBTL4, L3MBTL4-AS1, MIR4317
Not available 1 214,458,533 C CT 0.46 0.45 1.046 (1.030–1.063) 0.045 0.008 3.67e−08 0.99 PTPN14, SMYD2
Gastroenteritis rs115809651 4 162,414,623 A G 0.0014 0.00046 3.525 (2.359–5.269) 1.260 0.205 8.07e−10 0.86 FSTL5
rs138491114 22 47,432,980 A G 0.0035 0.0018 1.986 (1.557–2.532) 0.686 0.124 3.14e−08 0.97 TBC1D22A
rs772878892 16 49,404,415 G A 0.0011 0.00032 3.597 (2.274–5.690) 1.280 0.234 4.77e−08 0.90 C16orf78, CBLN1
 a. Bacterial gastroenteritis rs143977447 5 164,646,152 A C 0.011 0.0053 2.375 (1.787–3.156) 0.865 0.145 2.20e−09 0.85
rs547484470 7 68,931,296 A C 0.0045 0.0014 3.710 (2.396–5.744) 1.311 0.223 4.13e−09 0.88
 b. Viral gastroenteritis rs116879283 7 52,434,143 C T 0.017 0.0063 2.956 (2.033–4.299) 1.084 0.191 1.49e−08 0.90
Heart infections rs564399474 13 54,865,197 G A 0.016 0.0039 4.527 (2.930–6.994) 1.510 0.222 1.02e−11 0.93 MIR1297
rs182592259 14 96,788,318 A T 0.016 0.005 3.589 (2.323–5.546) 1.278 0.222 8.73e−09 0.88 AK7, ATG2B, BDKRB1, BDKRB2, GSKIP
rs139809494 17 79,796,214 T C 0.019 0.0064 3.139 (2.117–4.655) 1.144 0.201 1.30e−08 0.96 ALYREF, ANAPC11, ARHGDIA, GCGR, MAFG, MAFG-DT, MCRIP1, NPB, P4HB, PCYT2, PPP1R27, PYCR1, SIRT7
rs2181386 14 94,039,907 G A 0.16 0.12 1.490 (1.294–1.716) 0.399 0.072 3.51e−08 1.00 UNC79
Respiratory tract infections rs28752520 6 32,584,739 C T 0.24 0.25 0.931 (0.911–0.951) − 0.072 0.011 1.77e−10 0.99 HLA-DQA1, HLA-DQB1, HLA-DQB1-AS1, HLA-DRB1, HLA-DRB5, HLA-DRB6
Not available 9 128,648,077 ATG A 0.34 0.35 0.937 (0.919–0.956) − 0.065 0.010 1.94e−10 0.98 PBX3
 a. Bacterial pneumonia rs374402947 16 89,154,513 T C 0.0014 0.00048 3.391 (2.300–4.998) 1.221 0.198 6.86e−10 0.88 ACSF3, CDH15, LINC00304, LINC02138
rs77438700 15 78,906,637 G A 0.064 0.074 0.839 (0.795–0.887) − 0.175 0.028 7.72e−10 0.97 CHRNA3, CHRNA5, CHRNB4, HYKK, PSMA4
rs532298826 4 138,378,079 A T 0.0016 0.00064 3.056 (2.093–4.461) 1.117 0.193 6.62e−09 0.80 LINC02172, PCDH18
rs763947133 5 127,719,333 T C 0.00098 0.00029 3.971 (2.466–6.393) 1.379 0.243 1.33e−08 0.81 FBN2
 b. Influenza and viral pneumonia rs376768393 3 154,969,551 C T 0.021 0.0064 3.850 (2.434–6.090) 1.348 0.234 8.57e−09 0.87 DWORF, LINC01487, MME
Sepsis rs532825748 1 169,752,583 G A 0.0078 0.0041 2.018 (1.586–2.568) 0.702 0.123 1.13e−08 0.89 C1orf112, METTL18, SCYL3, SELE, SELL
rs147389769 2 231,527,107 T C 0.007 0.0036 2.130 (1.638–2.769) 0.756 0.134 1.60e−08 0.83 CAB39, LINC01907
rs564716204 4 151,664,401 T C 0.0027 0.00092 3.353 (2.200–5.111) 1.210 0.215 1.90e−08 0.82 LRBA
rs539059490 6 122,025,326 G T 0.0073 0.0039 2.006 (1.567–2.568) 0.696 0.126 3.65e−08 0.89
Sexually transmitted diseases rs62441491 7 41,892,859 A G 0.056 0.018 3.438 (2.274–5.199) 1.235 0.211 4.73e−09 0.94 INHBA-AS1
Skin infections rs6595799 5 127,408,683 C T 0.28 0.27 1.092 (1.058–1.127) 0.088 0.016 2.39e−08 0.98 LINC01184, SLC12A2
Specified viral infections rs568156598 7 94,453,230 G A 0.0029 0.00091 3.747 (2.397–5.858) 1.321 0.228 6.68e−09 0.85 PPP1R9A
Urinary tract infections (UTI) rs771331833 8 118,513,358 A C 0.0013 0.00049 2.989 (2.096–4.262) 1.095 0.181 1.62e−09 0.93 MED30
Not available 3 47,875,364 A AT 0.009 0.0064 1.471 (1.285–1.684) 0.386 0.069 2.81e−08 0.90 DHX30, MAP4, MIR1226, SMARCC1
rs189319388 3 7,867,797 T C 0.0077 0.0055 1.527 (1.313–1.775) 0.423 0.077 4.63e−08 0.81 GRM7
 a. Cystitis rs192629083 7 14,037,179 T C 0.0077 0.0025 3.702 (2.396–5.721) 1.309 0.222 3.50e−09 0.86 ETV1
rs77261774 4 60,641,124 A G 0.034 0.02 1.788 (1.461–2.188) 0.581 0.103 1.49e−08 1.00 LINC02429
Urogenital (non-UTI) infections rs188692128 8 126,584,263 T C 0.005 0.0017 3.589 (2.282–5.645) 1.278 0.231 3.13e−08 0.85
Not available 1 240,891,604 T TA 0.0052 0.0018 3.456 (2.219–5.381) 1.240 0.226 4.30e−08 0.83 RGS7

Phenotypes are listed in alphabetical order.